Paradoxical activation of T cells via augmented ERK signaling mediated by a RAF inhibitor.
Callahan MK, Masters G, Pratilas CA, Ariyan C, Katz J, Kitano S, Russell V, Gordon RA, Vyas S, Yuan J, Gupta A, Wigginton JM, Rosen N, Merghoub T, Jure-Kunkel M, Wolchok JD.
Callahan MK, et al.
Cancer Immunol Res. 2014 Jan;2(1):70-9. doi: 10.1158/2326-6066.CIR-13-0160.
Cancer Immunol Res. 2014.
PMID: 24416731
Free PMC article.